Emily Field, head of European pharmaceutical research at Barclays, says U.S. President Donald Trump's executive order on drug ...

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for ...

President demands that drug companies start bringing costs ‘in line’ with those in other nations.

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

US President Donald Trump has signed an executive order telling drugmakers to cut prices to "most favoured nation" pricing.

Countries with universal healthcare systems have stronger bargaining power, which has allowed them to effectively negotiate ...

Trump signed an executive order to align US prescription drug prices with those paid by other developed nations, reviving the ...

The Executive Order issued by US President Donald Trump to enforce the most favoured nation prescription drug pricing in that ...

We are going to pay the lowest price there is in the world,” Trump said before signing the executive order, which was met with skepticism.

As in negotiations with foreign nations, minor concessions by drug companies are more likely than a true overhaul.

President Donald Trump wants drugmakers to work with his federal health department to reach an agreement on a most favored ...